IDC MarketScape: Worldwide Life Science R&D Decentralized Clinical Trial Technology Solutions 2022 Vendor Assessment

IDC MarketScape Figure

• Figure: IDC MarketScape Worldwide Life Science R&D Decentralized Clinical Trial Technology Solutions Vendor Assessment

IDC Opinion

IDC MarketScape Vendor Inclusion Criteria

Advice for Technology Buyers

Vendor Summary Profiles

• Clario

• Strengths

• Challenges

• Consider Clario When

• Clinical ink

• Strengths

• Challenges

• Consider Clinical ink When

• ICON

• Strengths

• Challenges

• Consider ICON When

• IQVIA

• Strengths

• Challenges

• Consider IQVIA When

• Medable

• Strengths

• Challenges

• Consider Medable When

• Medidata

• Strengths

• Challenges

• Consider Medidata When

• Science 37

• Strengths

• Challenges

• Consider Science 37 When

• Signant Health

• Strengths

• Challenges

• Consider SH When

• TCS

• Strengths

• Challenges

• Consider TCS When

• THREAD

• Strengths

• Challenges

• Consider THREAD When

• Wipro

• Strengths

• Challenges

• Consider Wipro When

• Vendors to Watch

Appendix

• Reading an IDC MarketScape Graph

• IDC MarketScape Methodology

• Market Definition

• Market Overview

• Strategies and Capabilities Criteria

• Table: Key Strategy Measures for Success: Worldwide Life Science R&D Decentralized Clinical Trial Technology Solutions

• Table: Key Capability Measures for Success: Worldwide Life Science R&D Decentralized Clinical Trial Technology Solutions

• Table: Vendors Covered in This IDC MarketScape, 2022

Learn More

• Related Research

• Synopsis